glp-1 camp New Insights into Beta-Cell Receptor and Signaling Cyclic Adenosine Monophosphate in Cardiac

Winning companies will be those that build a full obesity care value proposition, not just a drug portfolio

The 5-year survival rate of patients undergoing surgical resection is only 25% [3]

A tiny measurement difference of just 2-3 units means you are off by 0.1-0.15mg

Umbilical cord blood-derived M1 macrophage exosomes loaded with Cisplatin target ovarian cancer in vivo and reverse Cisplatin resistance

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (surpass-3): A randomised, open-label, parallel-group, phase 3 trial